Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPD489 in healthy males with acute sleep loss
NCT01096680Phase 2Completed
- Sponsor
- Takeda
- Start
- Apr 2010
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lisdexamfetamine in sleep deprivation, sponsored by Takeda. Started Apr 2010; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
sleep deprivation
Beyond the preview
Go deeper on NCT01096680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01096680.